Find
Feb 17, 2016

Eurex

GlaxoSmithKline PLC: Extraordinary dividend

The Executive Board of the company GlaxoSmithKline PLC announced to pay a dividend of GBp 43 per share. According to a message of the company, GBp 20 thereof can be considered as extraordinary dividend.

The extraordinary dividend will result in an adjustment of the Eurex option, the Eurex Single Stock Futures contract and the Single Stock Dividend Futures contract on shares of GlaxoSmithKline PLC (GXO, GSKG, G3SK).

Ex date will be 18 February 2016.

This circular contains a description of the adjustment procedure.

Market Status

XEUR

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message. 

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.